Moderna
MRNA
#1308
Rank
ยฃ12.58 B
Marketcap
ยฃ32.20
Share price
-5.95%
Change (1 day)
0.41%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -ยฃ2.42 Billion

According to Moderna 's latest financial reports the company's current earnings are ยฃ2.20 Billion. In 2024 the company made an earning of -ยฃ2.62 Billion, an increase over its 2023 earnings that were of -ยฃ2.86 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ2.42 Billion-7.64%
2024 -ยฃ2.62 Billion-8.22%
2023 -ยฃ2.86 Billion-140.65%
2022 ยฃ7.01 B-27.81%
2021 ยฃ9.72 B-1911.15%
2020 -ยฃ0.54 Billion44.7%
2019 -ยฃ0.38 Billion28.63%
2018 -ยฃ0.29 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ23.67 B-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.99 B-622.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ16.87 B-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-ยฃ34.66 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ85.98 Million-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ30.52 Million-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ95.22 M-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
ยฃ0.10 B-104.48%๐Ÿ‡บ๐Ÿ‡ธ USA